Cargando…
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
The novel, highly contagious coronavirus SARS-CoV-2 spreads rapidly throughout the world, leading to a deadly pandemic of a predominantly respiratory illness called COVID-19. Safe and effective anti-SARS-CoV-2 vaccines are urgently needed. However, emerging immunological observations show hallmarks...
Autores principales: | Kleen, Thomas-Oliver, Galdon, Alicia A., MacDonald, Andrew S., Dalgleish, Angus G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498663/ https://www.ncbi.nlm.nih.gov/pubmed/33013871 http://dx.doi.org/10.3389/fimmu.2020.02059 |
Ejemplares similares
-
Immunometabolic Pathways in BCG-Induced Trained Immunity
por: Arts, Rob J.W., et al.
Publicado: (2016) -
The influence of the gut microbiome on BCG-induced trained immunity
por: Stražar, Martin, et al.
Publicado: (2021) -
Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
por: Buffen, Kathrin, et al.
Publicado: (2014) -
BCG-induced trained immunity: history, mechanisms and potential applications
por: Chen, Jingjing, et al.
Publicado: (2023) -
BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander?
por: Koneru, Gopala, et al.
Publicado: (2021)